#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3225697	F	Antiproliferative activity against human HCT116 cells assessed as growth inhibition after 24 to 72 hrs by MTS assay	Homo sapiens	4	ALA3217663	cell-based format	Scientific Literature
2.	ALA3225698	F	Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 24 to 72 hrs by MTS assay	Homo sapiens	3	ALA3217663	cell-based format	Scientific Literature
3.	ALA3225699	F	Antiproliferative activity against human MDA-MB-231 cells assessed as growth inhibition after 24 to 72 hrs by MTS assay	Homo sapiens	2	ALA3217663	cell-based format	Scientific Literature
4.	ALA3225700	A	Antiproliferative activity against NHDF assessed as growth inhibition after 24 to 72 hrs by MTS assay	Homo sapiens	3	ALA3217663	cell-based format	Scientific Literature
5.	ALA3225701	A	Antiproliferative activity against NHLF assessed as growth inhibition after 24 to 72 hrs by MTS assay	Homo sapiens	3	ALA3217663	assay format	Scientific Literature
6.	ALA3225702	A	Antiproliferative activity against HUVEC assessed as growth inhibition after 24 to 72 hrs by MTS assay	Homo sapiens	3	ALA3217663	cell-based format	Scientific Literature
7.	ALA3225703	A	Antiproliferative activity against HMEC assessed as growth inhibition after 24 to 72 hrs by MTS assay	Homo sapiens	3	ALA3217663	cell-based format	Scientific Literature
8.	ALA3226073	T	Toxicity in mouse assessed as death at 0.03 to 3 mg/kg, iv once every 4 days for 3 injections	Mus musculus	2	ALA3217663	organism-based format	Scientific Literature
9.	ALA3226074	T	Toxicity in mouse assessed as body weight loss at 0.03 to 3 mg/kg, iv once every 4 days for 3 injections	Mus musculus	1	ALA3217663	organism-based format	Scientific Literature
10.	ALA3226081	F	Antitumor activity against human HCT116 cells xenografted in NCr-nu/nu mouse assessed as tumor weight reduction at 1.5 to 3 mg/kg, iv once every 4 days for 3 injections after 16 days of tumor cell transplantation	Homo sapiens	2	ALA3217663	organism-based format	Scientific Literature
11.	ALA3226082	F	Antitumor activity against human HCT116 cells xenografted in NCr-nu/nu mouse assessed as tumor weight reduction at 6 mg/kg, iv once every 4 days for 3 injections after 16 days of tumor cell transplantation	Homo sapiens	1	ALA3217663	organism-based format	Scientific Literature
12.	ALA3226090	A	Therapeutic index, ratio of GI50 for human HCT116 cells to GI50 for NHDF	Homo sapiens	2	ALA3217663	cell-based format	Scientific Literature
13.	ALA3226091	A	Therapeutic index, ratio of GI50 for human HCT116 cells to GI50 for NHLF	Homo sapiens	2	ALA3217663	cell-based format	Scientific Literature
14.	ALA3226092	A	Therapeutic index, ratio of GI50 for human HCT116 cells to GI50 for HMEC	Homo sapiens	2	ALA3217663	cell-based format	Scientific Literature
15.	ALA3226093	A	Therapeutic index, ratio of GI50 for human HCT116 cells to GI50 for HUVEC	Homo sapiens	2	ALA3217663	cell-based format	Scientific Literature
16.	ALA3226094	A	Half life in mouse serum	Mus musculus	2	ALA3217663	assay format	Scientific Literature
17.	ALA5151308	F	Cytotoxicity against human MCF7 cells incubated for 7 to 10 days by MTS assay	Homo sapiens	2	ALA5149986	cell-based format	Scientific Literature
18.	ALA5151312	F	Cytotoxicity against mouse L1210 cells assessed as inhibition in cell growth	Mus musculus	5	ALA5149986	cell-based format	Scientific Literature
19.	ALA5151313	F	Cytotoxicity against human HCT-116 cells assessed as inhibition in cell growth	Homo sapiens	5	ALA5149986	cell-based format	Scientific Literature
20.	ALA5151314	F	Cytotoxicity against human HCT116/VM46 cells assessed as inhibition in cell growth	Homo sapiens	5	ALA5149986	cell-based format	Scientific Literature